The World Health Organization (WHO), in an update yesterday on 18 Saudi MERS-CoV cases, said that 5 of the 18 cases involved contact with camels before symptom onset.
Some problems became more apparent with age, and the follow-up findings could help providers plan care for other babies born with Zika-related defects.
The Centers for Disease Control and Prevention (CDC), in an update on an ongoing outbreak of multi-drug resistant Campylobacter infections linked to puppies sold in pet shops today, confirmed 30 new cases reported since the last outbreak update published on Oct 30.
No link was found between microcephaly and a key insecticide—or vaccines.
Health officials in Hildago County on Dec 7 reported three recent Zika cases, one of which appears to have been transmitted locally by mosquitoes, the Texas Department of State Health Services (TDSHS) said yesterday in a statement.
Boston University's National Emerging Infectious Disease Laboratories (NEIDL) received final approval from the Boston Public Health Commission to conduct biosafety level 4 (BSL-4) research, clearing the final hurdle to begin work on some of the world's most lethal pathogens, such as Ebola and Marburg virus, BU Today, the campus newspaper, reported.
The Saudi Arabian Ministry of Health (MOH) reported a new case of MERS-CoV in Sakaka, a city in the northwestern corner of the country.
A 64-year-old Saudi man is in stable condition after presenting with symptoms of MERS-CoV (Middle East respiratory syndrome coronavirus) infection. His source of infection is listed as "primary," meaning it's unlikely he contracted the virus from another person.
Trials of both an inactivated and a DNA vaccine showed good safety and immune response data.
In the past month the Pan American Health Organization (PAHO) has reported 1,106 new chikungunya infections, bringing the yearly total to 184,636 confirmed, suspected, and imported cases.
Japan-based Takeda announces the launch of a phase 1 trial of its Zika vaccine.
